U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H14F3N3O3S
Molecular Weight 385.3626
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5-HYDROXYLANSOPRAZOLE

SMILES

Cc1c(CS(=O)c2nc3ccc(cc3[nH]2)O)nccc1OCC(F)(F)F

InChI

InChIKey=IDCLTMRSSAXUNY-UHFFFAOYSA-N
InChI=1S/C16H14F3N3O3S/c1-9-13(20-5-4-14(9)25-8-16(17,18)19)7-26(24)15-21-11-3-2-10(23)6-12(11)22-15/h2-6,23H,7-8H2,1H3,(H,21,22)

HIDE SMILES / InChI

Molecular Formula C16H14F3N3O3S
Molecular Weight 385.3626
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Jun 26 11:18:44 UTC 2021
Edited
by admin
on Sat Jun 26 11:18:44 UTC 2021
Record UNII
N5ROU3WS91
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
5-HYDROXYLANSOPRAZOLE
Common Name English
AG-1908
Code English
M-VI
Code English
1H-BENZIMIDAZOL-6-OL, 2-(((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL)METHYL)SULFINYL)-
Systematic Name English
Code System Code Type Description
PUBCHEM
9800271
Created by admin on Sat Jun 26 11:18:44 UTC 2021 , Edited by admin on Sat Jun 26 11:18:44 UTC 2021
PRIMARY
FDA UNII
N5ROU3WS91
Created by admin on Sat Jun 26 11:18:44 UTC 2021 , Edited by admin on Sat Jun 26 11:18:44 UTC 2021
PRIMARY
CAS
131926-98-2
Created by admin on Sat Jun 26 11:18:44 UTC 2021 , Edited by admin on Sat Jun 26 11:18:44 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
the 5-hydroxylation of lansoprazole is primarily catalyzed by CYP2C19.
PARENT -> METABOLITE
These metabolites have very little or no antisecretory activity.